|
Dymkov I.N., Perlina A.D., Terentiev I.V., Prokopenko E.I., Kulikov P.А., Perlin D.V.
COVID-19 and viral dermal diseases in patients after renal transplantation
|
№1 / 2022
|
|
Shilov E.M., Shilova M.M., Rumyantseva E.I., Yesayan A.M., Kotenko O.N.
The state of the nephrological service in the Russian Federation: renal replacement therapy in the period from 2017 to 2021
|
№1 / 2022
|
|
Discussion club on nephrology «Modern view on the therapy of secondary hyperparathyroidism in hemodialysis patients»
|
№4 / 2021
|
|
T.Sh. Morgoshiia, A.Z. Gafarova, E.A. Bezuglaya, D.V. Monakhova, M.M. Zhumatov
In memory of academician of the USSR academy of medical sciences M.S. Vovsi (1897–1960) – chief therapist of the red and soviet armies, an outstanding scientist
|
№4 / 2021
|
|
L.V. Mikhailova, D.O. Sheleg, R.S. Bogachev
COVID-19 and kidney damage
|
№4 / 2021
|
|
Z.R. Bashirova, I.M. Osmanov
Association of proteolysis factors with progression of autosomal dominant polycystic kidney disease in children
|
№4 / 2021
|
|
A.V. Mukhtarova, M.M. Batyushin, E.А. Sinelnik, N.V. Antipova, A.V. Razina
Effect of VEGF a on the development of tubulointerstitial fibrosis and the probability of achieving complete remission in patients with primary chronic glomerulonephriti
|
№4 / 2021
|
|
A.P. Rebrov, E.V. Grigoryeva, G.S. Petrov, J.I. Vorobieva, M.S. Sitnikova
Patients receiving renal replacement therapy with hemodialysis and taking NSAIDS: real clinical practice
|
№4 / 2021
|
|
V.Kh. Sharipova, N.F. Berdiev, O. K. Lutfullaev, M.I. Zhabborova
NGAL as a marker of acute kidney injury in sepsis
|
№4 / 2021
|
|
O.N. Kotenko, V.V. Omelyanovskiy, V.I. Ignatyeva, Е.Е. Yagnenkova, E.I. Rumyantseva
The costs of chronic kidney disease in Russian Federation
|
№4 / 2021
|
|
D.V. Artemov
The use of a complex of ferric oxyhydroxide, sucrose and starch (Velforo 500) in patients on programmed hemodialysis in the routine practice of an outpatient dialysis center: results of a prospective randomized trial
|
№4 / 2021
|
|
D.S. Sedov, E.A. Fedotov, A.P. Rebrov
Determination of serum n-terminal pro-brain natriuretic peptide and soluble st2 receptor levels for the prediction of cardiovascular events in patients receiving «on-line» hemodiafiltration
|
№4 / 2021
|
Русский
